Patients
305 patients (mean age 64 y, 54% men) who had histologically documented cancer of the GI tract and planned major elective surgery. Exclusion criteria included weight loss ≥ 10% (with respect to usual body weight) in the past 6 months, age < 18 years, and hepatic dysfunction (Child-Pugh class > B). Follow up was 100%.
Intervention
Patients were allocated to PSUP (n=102), POEN (n=101), or COTR (n=102). Before surgery, patients in the PSUP group were asked to drink one l/d of Oral Impact® (Novartis Consumer Health, Bern, Switzerland), a supplemented liquid diet containing arginine (12.5 g/l), -3 fatty acid (3.3 g/l), and RNA (1.2 g/l) for 5 consecutive days. Patients in the POEN group received the same preoperative treatment as the PSUP group plus postoperative jejunal infusion with Impact®. Patients in the COTR group did not receive any artificial nutrition before or after surgery.
Main outcome measures
Incidence of postoperative infections and length of postoperative hospital stay.
Main results
Analysis was by intention to treat. Fewer patients in each of the PSUP and POEN groups than in the COTR group developed postoperative infections (table). The length of postoperative hospital stay was shorter in each of the PSUP and POEN groups than in the COTR group (table) . The PSUP and POEN groups did not differ for postoperative infections or length of postoperative hospital stay (table) .
Conclusion
Preoperative supplementation with or without postoperative enteral nutrition with key nutrients was more effective than conventional treatment for reducing postoperative infections and length of hospital stay in well nourished patients with cancer of the gastrointestinal tract. 
COMMENTARY
Although the GI tract is an essential barrier to the absorption of gut antigens, it is less effective in malnourished patients. 1 Hence, artificial nutritional has generally been aimed at malnourished patients or those who cannot resume normal diets soon after surgery. Recently, efforts towards strengthening patients' defences to infection have resulted in the increased use of immunonutrition. The common ingredients of immunonutrition formulas include arginine, glutamine, and omega 3 essential fatty acids.
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The trial by Gianotti et al differs from previous studies in that it investigated immunonutrition in nourished or well nourished patients and included an unsupplemented control group. The finding that immunonutrition was more effective than no supplementation for reducing postoperative infection in well nourished patients with cancer of the GI tract is sufficient impetus for change in standard practice.
Cost will be a factor for many clinicians in making this change in practice. Immunonutrition is expensive, and the potential savings from a decrease in expensive infectious complications and reduced length of hospital stay are not always recognised when hospital budgets are prepared. However, in considering the cost implications of this study it should be noted that the study also measured the additional benefit of POEN and found no added benefit above PSUP alone. PSUP orally by patients is not only less invasive with fewer side effects than enteral feeding but has the added advantage of allowing patients more independence. It is also likely to be a more attractive option for hospitals than POEN feeding, which requires costly equipment and is more time consuming for nursing staff to manage. 
